Try a new search

Format these results:

Searched for:

in-biosketch:true

person:bermar01

Total Results:

220


Deletion of PTENP1 Pseudogene in Human Melanoma

Poliseno, Laura; Haimovic, Adele; Christos, Paul J; Vega Y Saenz de Miera, Eleazar C; Shapiro, Richard; Pavlick, Anna; Berman, Russell S; Darvishian, Farbod; Osman, Iman
PMCID:3213301
PMID: 21833010
ISSN: 1523-1747
CID: 141068

Clinical Relevance of Detection of Lymphovascular Invasion in Primary Melanoma Using Endothelial Markers D2-40 and CD34

Rose, Amy E; Christos, Paul J; Lackaye, Dan; Shapiro, Richard L; Berman, Russell; Mazumdar, Madhu; Kamino, Hideko; Osman, Iman; Darvishian, Farbod
Immunohistochemistry (IHC) using endothelial markers may facilitate the detection of lymphovascular invasion (LVI) in primary melanoma; however, the clinical implications of enhanced detection are unknown. We evaluated whether the use of lymphatic endothelial marker D2-40 and panvascular marker CD34 increases LVI positivity relative to routine histology alone and then evaluated the prognostic relevance of LVI detected using these markers in terms of disease-free (DFS) and overall survival (OS). A total of 246 primary melanomas were assessed for LVI using D2-40, CD34, and routine histology. Associations between LVI positivity and clinicopathologic variables, DFS, and OS were compared using univariate and multivariate analyses. The use of endothelial markers increased the rate of LVI positivity (18% using D2-40 and/or CD34 vs. 3% by routine histology, P<0.0001). On univariate analysis, IHC-detected LVI was significantly associated with more adverse clinicopathologic variables (thickness, ulceration, mitoses, and nodular subtype) compared with LVI detected by routine histology (thickness and ulceration only). In a multivariate model controlling for stage, LVI detected using IHC markers remained a significant marker of both reduced DFS [hazard ratio (HR), 2.01; 95% confidence interval (CI): 1.27-3.18; P=0.003] and OS (HR, 2.08; 95% CI: 1.25-3.46; P=0.005). Results show that D2-40 and CD34 increase the detection of LVI in primary melanoma and that cases missed by routine histology have prognostic relevance
PMCID:3623282
PMID: 21881483
ISSN: 1532-0979
CID: 137842

ALK-negative anaplastic large cell lymphoma mimicking a soft tissue sarcoma

Hudacko, Rachel; Rapkiewicz, Amy; Berman, Russell Scott; Simsir, Aylin
Anaplastic lymphoma kinase protein (ALK)-negative anaplastic large cell lymphoma (ALCL) has a vast morphologic spectrum and may mimic many other types of malignancies both cytologically and histologically. There are only a few published case reports/series describing the cytomorphologic features of ALCL on fine-needle aspiration (FNA) biopsy specimens. We describe a case of ALK-negative ALCL mimicking a high-grade soft tissue sarcoma of the thigh in a 62-year-old man. The characteristic morphologic findings on FNA and core biopsy along with the immunophenotypic profile are described and reviewed. The diagnosis of ALCL on FNA biopsy may be difficult, but can be done successfully with the use of ancillary tests. Therefore, it must be considered in the differential diagnosis of lesions with pleomorphism, anaplasia, and wreath-like or horseshoe-shaped nuclei to ensure that adequate material is obtained for ancillary studies
PMCID:3214476
PMID: 22090705
ISSN: 0974-5165
CID: 141462

Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities

Wich, Lindsay G; Ma, Michelle W; Price, Leah S; Sidash, Stanislav; Berman, Russell S; Pavlick, Anna C; Miller, George; Sarpel, Umut; Goldberg, Judith D; Osman, Iman
Minority melanoma patients have worse survival. In this study, we evaluated the impact of socioeconomic and demographic factors on minority melanoma patients presenting to two different New York City hospitals (one public and one private) managed by the same multidisciplinary team. Sociodemographic and clinicopathologic characteristics were retrieved for melanoma patients presenting to Bellevue Hospital Center (BHC), a public hospital, and the New York University Cancer Institute (NYUCI), a private cancer center. Socioeconomic data was obtained from the United States Census Bureau database. The Kruskal-Wallis and chi-square tests were used to evaluate the associations between race/ethnicity and continuous and categorical variables (e.g. income, stage at presentation), respectively. Minorities comprised 2% (27/1296) of melanoma patients at the NYUCI compared to 42% (50/119) at BHC. Those presenting to the NYUCI were more likely to have a higher median household income (P = 0.05), a higher educational level (P = 0.04), and an earlier stage at presentation (P = 0.02) than those at BHC. NYUCI patients were predominantly covered by commercial insurance (70%), whereas Medicaid (62%) was common among BHC patients. Only 19% of Hispanic patients at BHC chose English as their preferred language. Our data demonstrate that language and health care system factors affect melanoma presentation in minorities
PMCID:3881593
PMID: 21080042
ISSN: 1573-3610
CID: 138281

Distinguishing between nodular and superficial spreading melanoma using specific microRNA alterations. [Meeting Abstract]

Poliseno, L.; Haimovic, A.; Hanniford, D.; Segura, M. F.; Christos, P. J.; Shapiro, R. L.; Pavlick, A. C.; Berman, R. S.; Hernando, E.; Zavadil, J.; Osman, I.
ISI:000208880302399
ISSN: 0732-183x
CID: 3159572

Impact of immune modulation on sentinel lymph node positivity and outcome in melanoma patients. [Meeting Abstract]

Medicherla, R. C.; Ma, M. W.; Qian, M.; de Miera, E. Vega-Saenz; Berman, R. S.; Shapiro, R. L.; Pavlick, A. C.; Bhardwaj, N.; Shao, Y.; Osman, I.; Darvishian, F.
ISI:000208880302420
ISSN: 0732-183x
CID: 3159682

An analysis of altered melanoma matrix metalloproteinase-23 (MMP-23) expression and response to immune biologic therapy. [Meeting Abstract]

Krogsgaard, M.; Ma, M. W.; Friedman, E. B.; de Miera, E. Vega-Saenz; Darvishian, F.; Perez-Garcia, A.; Berman, R. S.; Shapiro, R. L.; Christos, P. J.; Osman, I.; Pavlick, A. C.
ISI:000208880302400
ISSN: 0732-183x
CID: 3159202

Impact of population genetic substructure on association studies and risk assessment for melanoma [Meeting Abstract]

Lobach, I.; Belitskaya-Levy, I.; Goldberg, J. D.; Ostrer, H.; Berman, R. S.; Pavlick, A. C.; Shapiro, R. L.; Osman, I.; Manga, P.
ISI:000208880302382
ISSN: 0732-183x
CID: 3159452

An analysis of sera-based microRNAs as biomarkers of recurrence in melanoma [Meeting Abstract]

Friedman, E. B.; Shang, S.; de Miera, E. Vega-Saenz; Ma, M. W.; Berman, R. S.; Shapiro, R. L.; Pavlick, A. C.; Hernando, E.; Shao, Y.; Osman, I.
ISI:000208880302374
ISSN: 0732-183x
CID: 3159172

Primary melanoma features associated with increased risk of brain metastasis. [Meeting Abstract]

Ma, M. W.; Qian, M.; Lackaye, D.; Berman, R. S.; Shapiro, R. L.; Pavlick, A. C.; Golfinos, J.; Parker, E.; Hernando, E.; Shao, Y.; Osman, I.
ISI:000208880302419
ISSN: 0732-183x
CID: 3159422